State Of Wyoming Atara Biotherapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $15,866 - $33,288	-3,383 Reduced 90.62%	350 $3,000
Q1 2022 May 13, 2022	BUY	$8.44 - $16.89 $5,983 - $11,975	709 Added 23.45%	3,733 $35,000
Q4 2021 Feb 11, 2022	BUY	$14.7 - $19.89 $1,190 - $1,611	81 Added 2.75%	3,024 $48,000
Q3 2021 Feb 11, 2022	SELL	$11.99 - $17.9 $27,301 - $40,758	-2,277 Reduced 43.62%	2,943 $53,000
Q2 2021 Feb 11, 2022	BUY	$12.89 - $16.58 $41,621 - $53,536	3,229 Added 162.18%	5,220 $81,000

Q1 2021 Feb 08, 2022	BUY	$14.0 - $20.72 $27,874 - $41,253	1,991 New	1,991 $29,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.